The initial observation of increased LACV susceptibility of Efna2−/− (m) adult mice with mixed Efna3/5 deficiency suggested that the EphrinA molecules might have a role in resistance to LACV-induced neurologic disease. The gene discussed is EFNA3; the disease is nervous system disorder.